Safety and efficacy assessment of Synskin triple action eye contour cream
Phase 2
Recruiting
- Conditions
- periorbital wrinkle, dark circle and puffiness.
- Registration Number
- IRCT20210130050179N1
- Lead Sponsor
- Iran Avandfar Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Male or female aged 30-60 years
The presence of periorbital wrinkle, dark circle and puffiness
No change in life style during the study
Signed informed consent knowingly
Exclusion Criteria
Critical untreated systemic disease in medical history
Any facial rejuvenation treatment, including treatment with topical or oral products or supplements during the last four weeks
Any facial rejuvenation treatment including rejuvenation devices or surgical procedures and Botox injections during the last four months
Sensitivity and allergy to the components of the formulation
Use of any eye cream or eye sunscreen cream during the last four weeks
Use of anti-wrinkle or brightening cleansers over the past four weeks
Pregnancy or lactation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of periorbital wrinkle, dark circle and puffiness by three independent physician using 0-3 scale. Timepoint: Before intervention and 4 and 8 weeks after treatment. Method of measurement: Three independent dermatologists perform evaluation and scoring with the help of right and left lateral view and full face photos based on the percentage of improvement in periorbital wrinkles, dark circle and puffiness using scale 0 to 3 (0 = no improvement 1 = relative improvement 2 = good improvement 3 = Excellent improvement) .
- Secondary Outcome Measures
Name Time Method